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Background: Papular urticaria by flea bite (PUFB) is a chronic inflammatory disease in children. The aim of this
study was to assess the functional activity of IgE to protein fractions from flea body extract, through basophil
degranulation in PUFB patients and controls.
Methods: Basophil degranulation, measured by overexpression of CD63 surface molecules, was evaluated by flow
cytometry in samples from patients and controls. Cell stimulation was performed with three fractions with different
molecular weight from flea body extract using a BasotestW modified protocol. Mann–Whitney U-test was used for
comparisons.
Results: Specific IgE from PUFB patients and healthy controls induced basophil degranulation to flea body extract
with no significant differences between them (16.2 ± 3.1% vs 13.6 ± 2.8% p = 0.77). However, when flea extract was
analyzed in fractions with proteins ranging different molecular weights, significant differences were observed on the
response from patients compared with controls to <50 kD (14.9 ± 5.1% vs 9.7 ± 2.1% p = 0.0058) and 50–100 kD
proteic fractions (8.3 ± 3.2% vs 2.8 ± 1.6% p = 0.0021).
Conclusion: In this study, was established that the differential response by IgE, in PUFB, depends from the molecular
weight of the antigens contained in the flea extract. These antigens may be related to 30–35 kD proteins previously
described as major allergens.
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Papular urticaria by flea bite (PUFB) is a chronic inflam-
matory disease clinically observed during the first years
of life, as a cutaneous hypersensitivity reaction [1]. In
Bogotá, Colombia, children with papular urticaria due to
flea bites, are part of the dermatologic practice all year
round. With its wet and temperate climate, Bogota is an
environment where fleas thrive, and their bites afflict to
the children. PUFB prevalence in child population be-
tween one to six years old in Bogota is 20.3%. The major* Correspondence: eligarcia.gomez@gmail.com
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distribution, and reproduction in any mediumrisk factor for this disease is the presence of fleas at
home. With this high prevalence, this disease is import-
ant in terms of public health. (Halpert E, Borrero E,
Chaparro P, et al.: Prevalencia de la urticaria papular por
picadura de pulga y factores asociados en niños de 1–6
años en la ciudad de Bogotá. Informe final Colciencias.
Código 622145921508. Article in preparation).
Previous studies showed a pattern of cellular infiltra-
tion in the lesions consisting primarily of eosinophils
and CD4+ T lymphocytes [2] and also it has been ob-
served a predominant Th2 response to a polyclonal
stimulus [3]. In addition, functional differences in den-
dritic cells derived from monocytes in patients comparedBioMed Central Ltd. This is an Open Access article distributed under the terms
(http://creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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described [4].
The total flea extract contains a large number of proteins
with a wide range of molecular weight whose are recognized
by IgE from PUFB patients and healthy controls. Proteins
with molecular weights ranging 30 and 35 kDa were recog-
nized by nearly 60% of patients. In addition, most of the rec-
ognized proteins by patients and controls, were those under
90 kDa [5]. Despite the advance in knowledge of the disease
immuno-pathogenesis, at this moment diagnostic and treat-
ment tools are not available for patient intervention.
Beside the complexity of the allergic reaction, the role
of the allergen-induced specific IgE, and its binding prop-
erties with receptors from cells like basophils, is com-
pletely clear. This leucocyte population is present in a
very low frequency in peripheral blood but plays an im-
portant role as effector cells in the allergic response. Ba-
sophils are characterized by a high expression of the
tetrameric form of the high affinity receptor for IgE, and
they can be activated by allergens in an IgE dependent
pathway to release inflammatory mediators as histamine,
leukotrienes and Th2 cytokines (IL-4 and IL-13) [6]. The
main feature of these cell population, the histamine re-
lease in response to the antigen, it has facilitated the stud-
ies of the immune response to allergens compared with
the study of the tissue mast cells [7].
The purpose of this study was to explore the capacity
of allergens with different molecular weights to induce
IgE mediated basophil degranulation. Bearing in mind the
recognition pattern, proteins from flea body extract were
fractioned, according their molecular weight, in <50 kDa,
50 – 100 kDa and >100 kDa.
Methods
Study population
It was done an observational analytical, cross-sectional
study, that included ten children with ages ranging from
two to ten years old (mean age 6.1 ± 3.2) with a clinical
diagnosis of papular urticaria induced by the flea bite
(PUFB), living in Bogota during the last year. Study par-
ticipants were recruited from the Pediatric Dermatology
and Allergy service in the Fundación Santa Fe de Bogotá,
in Bogotá, Colombia. As a control group, we included 10
children with similar age range (mean age 5.9 ± 2.9) whom
attended the same institution for minor surgical proce-
dures related to non-inflammatory pathologies. None of
the controls had a history of PUFB. An informed consent
form was signed by parents or guardians of the children.
The study was approved by the Institutional Review Boards
of the Fundación Santa Fe de Bogotá, in Bogotá, Colombia.
Disease diagnosis
The diagnosis of PUFB was carried out by clinical findings,
according the morphologic parameters that characterizethe disease. Briefly, papular urticaria from flea bites, usually
presents as grouped, pruritic lesions, ranging through an
oval urticarial flare, small solid papules, vesicles, bullae,
and crusted impetigo lesions to residual macules and small
pigmented areas. Individual papules may surround a wheal
and often have a central punctum or may have small cen-
tral vesicles in them. The eruption of papular urticaria of-
ten shows lesions of varied type at the same time. The
individual spots persist and go through a process of reso-
lution which takes several days until they are excoriated or
crusted. They are located where clothing fits snugly, such
as the sock line and waist band. Exposed areas of the
extremities are also commonly affected [1].
Flea antigen
Aqueous extracts (20% weight/volume) of complete flea
(Ctenocephalides felis) (Greer Labs, Lenoir, NC, USA)
were prepared. The fleas were stored at −70°C until pro-
cessing time; they were macerated in PBS and shook con-
stantly for 1 hour. The macerated was centrifuged at
15.000 rpm for 15 minutes at 4°C and then it was passed
through a 0.22 μm filter to ensure sterility. Protein con-
centration was determined by Bradford protein assay. The
flea body extract was fractioned by ultracentrifugation
using AmiconW tubes (Millipore, Billerica, MA, USA) on
three fractions including different proteins, comprised be-
tween 0–50 kDa, 50–100 kDa and >100 kDda molecular
weight ranges. For assays, it was used a flea extract con-
centration of 20 μg/mL based on a previous antigen titra-
tion curve.
Basophil degranulation test
To establish if the IgE that recognizes flea antigens is
functional and capable to induce basophil degranulation
in patients and healthy controls, it was carry out a baso-
phil degranulation test by flow cytometry using BasotestW
kit (Orpegen Pharma, Heidelberg, Germany. This kit con-
tains the chemotactic peptide N-formyl-Met-Leu-Phe
(fMLP) used as a positive control, and a two-color anti-
body reagent (anti-IgE-PE/anti-CD63 FITC) for assessing
the activation and degranulation of basophils. As a nega-
tive control was used the washing solution (from the kit).
Test was done follow the directions from manufacturer.
Characterization of cell populations by flow cytometry
To define the basophil population more precisely, we
included for the surface staining, markers for mole-
cules CD123-PerCP-Cy5,5 y HLA-DR-Pe-Cy7 (BD Biosci-
ences, San José, CA, USA), in addition to the antibodies
used to identify IgE and CD63 included in the BasotestW
kit. The phenotype of the basophil population was defined
as CD123+, IgE+, HLA-DR- for this assay. Basophil de-
granulation was measured by over-expression of CD63,
marker of late endosomes, which increases its expression
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the plasmatic membrane. Cells were acquired in a flow
cytometer FACSAria and analyzed with FACSDiva soft-
ware (BD Biosciences). At least 8x105 cells were analyzed
for each experiment.
Statistical analysis
A descriptive analysis was carried out on cell populations
using percentages, medians and standard deviations. Dif-
ferences among groups were determined by U Mann–
Whitney using GraphPad Prism 5.0. software. Differences
were considered statistically significant when p < 0.05.
Results
The protein concentration from the flea extract was
1.3 mg/mL, and fractions obtained by ultracentrifugation
showed ranges of molecular weight between 0–50 kDa,
50–100 kDa and >100 kDa (Figure 1).
IgE reactivity to the fractions was tested in vitro by its
capability to induce basophil degranulation. Basophil
population was gated based on the expression of mole-
cules CD123, IgE and HLA-DR. On this population, it
was analyzed the over-expression of the marker CD63 as
marker of degranulation (Figure 2A). Results showed
that specific IgE from patients with PUFB and healthy
controls induced a basophil degranulation response to
the flea extract with no significant differences between
them (16.2 ± 3.1% vs 13.6 ± 2.8% respectively p = 0.77)
(Figure 2B).
However, significant differences were observed on the
basophil degranulation response mediated by IgE, from
patients compared with healthy controls to <50 kDaFigure 1 Evaluation of efficiency of the fractionation of flea extract b
fractions (<50 Kda, 50–100 Kda and >100 Kda) and flea extract (FE). Cooma(14.9 ± 5.1% vs 9.7 ± 2.1% respectively p = 0.0058) and
50–100 kDa protein fractions (8.3 ± 3.2% vs 2.8 ± 1.6%
respectively p = 0.0021) (Figure 2B).Discussion
After repeated exposure to a particular antigen, atopic
people develop strong Th2 responses with IgE produc-
tion. This specific IgE sensitizes mast cells and basophils
by binding and up-regulation of their FcεRI receptors.
Subsequent exposures to the same antigen activate the
mast cells and basophils resulting in pathological reac-
tions of immediate hypersensitivity providing a mechan-
ism for the amplification of IgE-mediated reactions [8].
In vivo properties from basophils have been ignored
for a long time because their low frequency in peripheral
blood and the absence of specific markers to identify
them, but recently, it has been established the important
role of these cells on the initial phases of the chronic
allergic inflammation mediated by IgE in an indepen-
dent way from T and mast cells [9,10] like orchestrators
of the response to allergens by Th2 cells because their
capacity to present antigens in the MHC class II mole-
cules context [8,11,12] and cytokine production as re-
sponse to IL-4 [8].
Histological analysis of infiltrates from skin patholo-
gies have revealed presence of basophils in tissue lesions
from patients with atopic dermatitis, prurigo, urticaria and
insect bites but not in biopsies from psoriasis vulgaris,
tumoral lesions, mastocytosis, systemic sclerosis and sys-
temic lupus erythematosus [13]. Given the importance of
basophils in chronic allergic inflammation and skiny SDS-PAGE. Electrophoretic pattern showed by three protein
sie blue staining.
Figure 2 Analysis of basophil degranulation induced by proteic fractions derived from flea extract. Representative Dot Plot of the
basophil degranulation induced by three protein fractions (<50 Kda, 50–100 Kda and >100 Kda) and flea extract (FE) (A). Frequency of basophil
degranulation induced by protein fractions and FE in PUFB patients and healthy controls (B). ** p < 0.1, *** p < 0.005.
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cell population in PUFB.
In vitro functional tests for diagnostic of allergic patholo-
gies have been focused on basophils because, in contrast
with mast cells, basophils are circulating in peripheral
blood and they could be easier to isolate [14]. In this study
was used a modified BasotestW protocol in which, in ad-
dition to the use of allergenic extracts from flea, made in
our laboratory, were included the anti-CD123 and anti-
HLA-DR fluorescent antibodies to define, more precisely,
the basophil population present in peripheral blood.
CD123 is the low-affinity subunit of the IL-3 receptor
and is expressed at high levels on plasmacytoid dendritic
cells (pDC) and basophils. However, in contrast to baso-
phils, pDC show a higher expression of HLA-DR mole-
cules for their role in antigen presentation [15]. Although
it has been proposed the use of other molecules as
markers of activated basophils, selection based on CD63/
CD123/HLA-DR expression provides an accurate method
for basophil identification [16-18]. In our case, the com-
bination of these markers allowed a better identification
of the basophil population, that was the reason because
we decided to modify the protocol and included anti-
bodies directed to HLA-DR and CD123 molecules to
characterize the basophil population. In addition, because
our interest was the functional activity of IgE, we focused
in the basophil population that carried IgE bind to their
surface.Allergen extracts are complex mixtures of macromole-
cules as proteins, glycoproteins and polysaccharides, this
mixture contains the major, intermediate and minor al-
lergens that must be identified to obtain clinically effect-
ive extracts for immunotherapy protocols and for allergy
diagnosis [19,20].
In this study, our results show that the response de-
rived from the interaction between allergens from flea
extract and the IgE+ basophils was not different between
PUFB patients and healthy controls. In contrast, when
the protein fractions derived from the complete extract
were used, we observed significant differences on the
basophil degranulation response induced by proteins
from 50–100 kDa and <50 kDa in the studied groups.
This results support the findings showing that the rele-
vant allergens in the immuno-pathogenesis of the disease
correspond to low molecular weight proteins, as previ-
ously was showed on the allergogram [4]. In addition, this
is a first report of the functional capability from specific
IgE antibodies to flea allergens to activate cells that
are important in the allergic immune response such
as basophils.
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